|Home | About | Journals | Submit | Contact Us | Français|
A 52‐year‐old patient with a history of psoriasis reported inflammatory back pain, painful ankles and knees and severe morning stiffness on admission. The physical examination revealed tender entheses at different locations: upper thoracic spine, lumbar spinous processes, both iliac crests and posterior superior iliac spines. Furthermore, there was tenderness of both sacroiliac joints, both knees and both ankles without joint swelling.
HLA‐B27 antigen was negative. The sedimentation rate (70/76) and levels of C reactive protein (1.48 mg/dl) were increased. The Bath Ankylosing Spondylitis Activity Index was 6.0, and the Bath Ankylosing Spondylitis Functional Index was 4.6. Radiographs of the pelvis showed bilateral grade 3 sacroiliitis. Thus, ankylosing spondylitis (AS) associated with psoriasis was diagnosed. Treatment on admission comprised methotrexate (15 mg/week) and prednisolone (5 mg/day). Whole‐body MRI (WB‐MRI) was performed on a special 1.5 T scanner (Avanto, Siemens, Germany) for evaluation of the extent of suspected widespread inflammatory lesions. Images of the entire body, excluding the hands, were acquired in a head‐to‐toe scan using parallel imaging and a whole‐body surface coil system. Total imaging time was about 65 min.
WB‐MRI detected multiple extensive foci of inflammatory spondylitis from C4 through T8 and T12 through L4 (fig 1A,B,E,F1A,B,E,F)) and erosive spondylodiscitis from C6 through C8 (fig 1B1B).). In addition, there was florid arthritis of various facet and costovertebral joints at the cervicothoracic junction. The sacroiliac joints showed grade 3 chronic changes4 and florid changes spreading into the sacral and iliac bone, predominantly on the right side (fig 1D, HH).). Erosions were found on the distal right tibia ((figfig 1C, G, 2C2C)) and on the left posterior calcaneus (fig 2D2D).). There was peripheral bone marrow oedema of the right sternoclavicular joint (fig 2A2A),), manubriosternal synchondrosis, right proximal tibia (fig 2B2B),), distal tibia (fig 2C2C),), distal fibula, navicular bone (fig 2D2D)) and posterior aspect of the left calcaneus (fig 2D2D).
This is the first report on the use of WB‐MRI in a patient with active AS. Remarkably, this technique allowed us to identify multiple disease manifestations with a single procedure. We could clearly correlate clinical symptoms with WB‐MRI findings: the painful lumbar spinal segments showed acute inflammatory changes, such as spondylitis and spondylodiscitis. The tender spinal segments showed acute inflammatory changes, such as spondylitis, spondylodiscitis, costovertebral joint arthritis and facet joint arthritis. Tenderness of the knee and ankle joints correlated with focal bone marrow oedema and erosive arthritis. In addition, mild subclinical enthesitis of the sternum was detected.
MRI is highly sensitive and superior to conventional radiography in depicting inflammatory bone lesions of the axial skeleton and peripheral arthritis.5,6,7 Normally, patients with multiple disease manifestations as in the case given here would need several examinations at different times on a conventional scanner (eg, sacroiliac joints, thoracic spine, hindfoot), which is usually not done in clinical practice because of budget limitations. The cost of WB‐MRI is about 1.4 times that of conventional MRI. WB‐MRI may be more cost effective than scanning at two separate locations (eg, sacroiliac joints and spine) in patients with suspected widespread inflammation. The use of novel coil systems and accelerated imaging techniques enables whole‐body scanning in about 60 min.8 Currently, the technique of WB‐MRI is still limited by the inability to include the finger and wrist joints in the imaging volume, because of the maximum width of the field of view.
The case presented here underlines the potential of WB‐MRI as an emerging tool in identifying widespread inflammation in patients with AS and other forms of SpA, which might be especially useful if expensive treatments such as anti‐tumour necrosis factor α agents are considered.
AS - ankylosing spondylitis
SpA - spondyloarthritis
WB‐MRI - whole‐body MRI
Competing interests: None declared.